cinacalcet has been researched along with CKD-MBD in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (37.78) | 29.6817 |
| 2010's | 21 (46.67) | 24.3611 |
| 2020's | 7 (15.56) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, JF; Chiu, HW; Hou, YC; Liu, WC; Lu, CL; Lu, KC; Shyu, JF; Zheng, CM | 1 |
| Choi, B; Han, S; Jung, JH; Kim, H; Lee, MJ; Park, C; Park, I; Park, RW; Shin, DH; Shin, GT; Son, M | 1 |
| Bacchetta, J; Bernardor, J; De Mul, A; Schmitt, CP | 1 |
| Cheung, SC; Lang, BH; Lo, WK; Tang, TK; Wang, AY; Yau, YY | 1 |
| Ayach, T; El-Husseini, A; Elyamny, M; Kakani, E | 1 |
| Ariceta, G; Bacchetta, J; Bakkaloglu, SA; Groothoff, J; Haffner, D; Schmitt, CP; Shroff, R; Vervloet, M; Wan, M | 1 |
| Ikeda, M; Maruyama, Y; Matsuo, N; Morishita, M; Nakao, M; Ohkido, I; Tanno, Y; Yokoo, T | 1 |
| Belozeroff, V; Chonchol, M; Danese, MD; Desai, P; Gleeson, M; Lin, TC; Lubeck, D; Martin, K | 1 |
| Ayav, C; Brunaud, L; Filipozzi, P; Frimat, L; Kessler, M; Laurain, E; Ngueyon Sime, W | 1 |
| Abdalla, S; Chertow, GM; Decker, BS; Foroud, TM; Lai, D; Long, J; Moe, SM; Vatta, M; Wetherill, L | 1 |
| Cozzolino, M | 1 |
| Bonewald, LF; Inaba, M; Ito, A; Nitta, K; Tanizawa, T; Tominaga, Y; Tsuchiya, K; Yajima, A | 1 |
| Eiam-Ong, S; Greeviroj, P; Jaber, BL; Katavetin, P; Kitrungphaiboon, T; Praditpornsilpa, K; Susantitaphong, P | 1 |
| Bellasi, A; Cancarini, G; Cozzolino, M; Esposito, C; Genderini, A; Guastoni, CM; Locatelli, F; Malberti, F; Messa, P; Ondei, P; Pontoriero, G; Teatini, U; Vezzoli, G | 1 |
| Hamano, T | 1 |
| Aleksinskaya, MA; de Bruin, RG; Fibbe, WE; Koekkoek, KM; Massy, ZA; Monge, M; Rabelink, TJ; Siebelt, M; Slot, EM; van Pel, M; van Zonneveld, AJ; Weinans, H | 1 |
| Chertow, GM; Decker, BS; Edenberg, HJ; Foroud, TM; Liu, S; Moe, SM; Schwantes-An, TH; Stedman, M; Vatta, M; Wetherill, L | 1 |
| Bhargava, R; Brenchley, P; Hann, M; Hurst, H; Hutchison, AJ; Kalra, PA | 1 |
| Albero-Molina, MD; Álvarez-Avellán, L; del Pozo-Fernández, C; López-Menchero-Martínez, R; Sánchez-Rodríguez, L | 1 |
| Hasegawa, E; Hayami, N; Hiramatsu, R; Hoshino, J; Imafuku, A; Kawada, M; Mise, K; Sawa, N; Sumida, K; Suwabe, T; Takaichi, K; Ubara, Y | 1 |
| Bouquegneau, A; Delanaye, P; Eastell, R; Khwaja, A; Salam, S | 1 |
| Agarwal, A; Busse, JW; Guyatt, GH; Lopes, LC; Mustafa, RA; Sekercioglu, MF; Sekercioglu, N; Shaikh, S; Thabane, L | 1 |
| Buttar, RS; Coco, M; Melamed, ML | 1 |
| Bockenhauer, D; El-Desoky, SM; Kari, JA; Sawan, ZA; Shalaby, MA | 1 |
| Fukagawa, M; Komaba, H; Tanaka, M | 1 |
| Malluche, HH; Mawad, H; Monier-Faugere, MC | 1 |
| Akizawa, T | 1 |
| Tahara, H | 1 |
| Akizawa, T; Ito, A; Kurihara, S; Tsukamoto, Y; Yajima, A | 1 |
| Alonso, M; Andrés, E; Ballarín, J; Bover, J; Canal, C; Farré, N; Olaya, MT; Quílez, B | 1 |
| Filson, J; Nguyen, TV | 1 |
| Burren, C; Dudley, J; Inward, C; McGraw, M; Platt, C; Saleem, MA; Tizard, J | 1 |
| Andres, A; Gutierrez, E; Morales, E | 1 |
| Mehls, O; Schmitt, CP | 1 |
| Imanishi, Y | 1 |
| Ogata, H; Taguchi, S; Yamamoto, M | 1 |
| Hirose, M; Koiwa, F | 1 |
| Cunningham, J; Fan, SL; Steddon, SJ | 1 |
| Matuszkiewicz-Rowińska, J | 1 |
| Lindberg, JS | 1 |
| Elder, GJ | 1 |
| Fottner, C; Weber, MM | 1 |
| Imanishi, Y; Inaba, M | 1 |
| Joy, MS; Karagiannis, PC; Peyerl, FW | 1 |
| Baker, N; Charytan, C; Coburn, JW; Coyne, DW; Frazã O, JM; Goodman, WG; Kaplan, MR; Malluche, HH; McCary, LC; Monier-Faugere, MC; Turner, SA; Wang, G | 1 |
22 review(s) available for cinacalcet and CKD-MBD
| Article | Year |
|---|---|
Impact of Cinacalcet and Etelcalcetide on Bone Mineral and Cardiovascular Disease in Dialysis Patients.
Topics: Adult; Calcimimetic Agents; Calcium; Cardiovascular Diseases; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Minerals; Parathyroid Hormone; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Vitamin D | 2023 |
Pathogenesis and management of vascular calcification in CKD and dialysis patients.
Topics: Calciphylaxis; Calcitriol; Cardiovascular Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Comorbidity; Female; Humans; Incidence; Kidney Failure, Chronic; Male; Prognosis; Renal Dialysis; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vascular Calcification; Vitamin D | 2019 |
Cinacalcet for Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: A Meta-Analysis of Randomized Controlled Trials.
Topics: Calcimimetic Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Fibroblast Growth Factor-23; Humans; Minerals; Randomized Controlled Trials as Topic | 2018 |
Mineral and bone disorders in conventional hemodialysis: Challenges and solutions.
Topics: Bone Density; Bone Density Conservation Agents; Calcium; Calcium-Regulating Hormones and Agents; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Fractures, Bone; Humans; Parathyroid Hormone; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Vascular Calcification | 2018 |
Bone Disease after Kidney Transplantation.
Topics: Absorptiometry, Photon; Bone Density Conservation Agents; Bone Diseases; Calcimimetic Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Fractures, Bone; Humans; Immunosuppression Therapy; Kidney Transplantation; Minerals; Osteoporosis; Parathyroid Hormone; Vitamin D; Vitamins | 2016 |
Cinacalcet versus standard treatment for chronic kidney disease: a systematic review and meta-analysis.
Topics: Calcimimetic Agents; Cardiovascular Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Fractures, Bone; Hospitalization; Humans; Parathyroid Hormone; Parathyroidectomy | 2016 |
CKD-Mineral Bone Disorder in Stage 4 and 5 CKD: What We Know Today?
Topics: Bicarbonates; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diet, Protein-Restricted; Fibroblast Growth Factor-23; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphates; Renal Insufficiency, Chronic; Vitamin D | 2016 |
Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Topics: Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Japan; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Vitamin D | 2008 |
Effects of treatment of renal osteodystrophy on bone histology.
Topics: Bone and Bones; Bone Remodeling; Calcification, Physiologic; Calcitriol; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Lanthanum; Naphthalenes; Parathyroid Hormone; Phosphates; Polyamines; Sevelamer; Vitamin D | 2008 |
Update on the treatment of chronic kidney disease-mineral and bone disorder.
Topics: Aluminum Compounds; Calcinosis; Calcium Carbonate; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diet, Protein-Restricted; Dietetics; Humans; Kidney Failure, Chronic; Lanthanum; Naphthalenes; Nephrology; Nutrition Assessment; Nutritive Value; Parathyroidectomy; Patient Care Team; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Sevelamer; Vitamin D | 2009 |
Treatment with calcimimetics in kidney transplantation.
Topics: Bone Diseases; Bone Diseases, Metabolic; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Graft Survival; Humans; Hypercalcemia; Hyperparathyroidism; Hypophosphatemia; Kidney Transplantation; Minerals; Naphthalenes; Postoperative Complications; Survival Analysis; Vitamin D Deficiency | 2010 |
Mineral and bone disorders in children with chronic kidney disease.
Topics: Child; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Homeostasis; Humans; Minerals; Naphthalenes; Renal Insufficiency, Chronic | 2011 |
[Kidney and bone update : the 5-year history and future of CKD-MBD. Bone fragility in the aged hemodialysis patients].
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diphosphonates; Fractures, Spontaneous; Homeostasis; Humans; Kidney Diseases; Minerals; Naphthalenes; Osteoporosis; Phosphorus; Renal Dialysis; Risk | 2012 |
[Prophylaxis and treatment of adynamic bone].
Topics: Animals; Bone and Bones; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Calcium; Carrier Proteins; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Epoxy Compounds; Glycoproteins; Humans; Hyperparathyroidism, Secondary; Membrane Glycoproteins; Naphthalenes; Osteoprotegerin; Parathyroid Hormone; Polyamines; Polyethylenes; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Calcitriol; Receptors, Calcium-Sensing; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Risk; Sevelamer; Transforming Growth Factor beta; Vitamin D | 2004 |
[Significance of point of no return in therapeutic strategy for treatment of renal osteodystrophy; from histopathological findings].
Topics: Biomarkers; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Down-Regulation; Ethanol; Humans; Hyperparathyroidism, Secondary; Injections, Intralesional; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Receptors, Calcitriol; Receptors, Calcium-Sensing; Vitamin D | 2004 |
New prospects for the management of renal bone disease.
Topics: Animals; Bone Remodeling; Calcium; Carrier Proteins; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Hyperparathyroidism; Hyperplasia; Membrane Glycoproteins; Naphthalenes; Osteoclasts; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Radiography; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Vitamin D | 2005 |
[New aspects in the management of renal osteodystrophy].
Topics: Calcinosis; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Controlled Clinical Trials as Topic; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Phosphates; Polyamines; Polyethylenes; Sevelamer | 2004 |
Calcimimetics: a new tool for management of hyperparathyroidism and renal osteodystrophy in patients with chronic kidney disease.
Topics: Aniline Compounds; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Phenethylamines; Propylamines; Vitamin D | 2005 |
Parathyroidectomy in the calcimimetic era.
Topics: Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Naphthalenes; Parathyroidectomy; Practice Guidelines as Topic; Risk Factors | 2005 |
[The latest developments in endocrinology 2004/2005].
Topics: Adrenal Gland Neoplasms; Adult; Bone Density Conservation Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Clinical Trials as Topic; Endocrinology; Eplerenone; Female; Humans; Hyperaldosteronism; Hyperparathyroidism; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hypogonadism; Hypothyroidism; Male; Naphthalenes; Neuroendocrine Tumors; Organometallic Compounds; Osteoporosis, Postmenopausal; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Radiography, Abdominal; Spironolactone; Teriparatide; Testosterone; Testosterone Congeners; Thiophenes; Time Factors; Tomography, X-Ray Computed | 2006 |
[Secondary hyperparathyroidism].
Topics: Adsorption; Blood Vessels; Calcinosis; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diagnosis, Differential; Ethanol; Humans; Hyperparathyroidism, Secondary; Injections, Intralesional; Kidney Failure, Chronic; Naphthalenes; Osteitis; Parathyroidectomy; Phosphorus; Prognosis; Renal Dialysis; Vitamin D | 2006 |
Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment.
Topics: Calcitriol; Cardiovascular Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Cost-Benefit Analysis; Drug Costs; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Renal Insufficiency, Chronic; Vitamin D; Vitamins | 2007 |
6 trial(s) available for cinacalcet and CKD-MBD
| Article | Year |
|---|---|
Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial.
Topics: Adult; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroidectomy; Peritoneal Dialysis; Prospective Studies; Quality of Life; Renal Dialysis; Renal Insufficiency, Chronic | 2023 |
Calcium-Sensing Receptor Genotype and Response to Cinacalcet in Patients Undergoing Hemodialysis.
Topics: Adult; Aged; Alkaline Phosphatase; Biomarkers; Black People; Calcimimetic Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Female; Fibroblast Growth Factor-23; Gene Frequency; Humans; Kidney Diseases; Linkage Disequilibrium; Male; Middle Aged; Parathyroid Hormone; Pharmacogenetics; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Receptors, Calcitriol; Receptors, Calcium-Sensing; Renal Dialysis; Time Factors; Treatment Outcome; White People | 2017 |
A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis.
Topics: Aged; Cardiovascular Diseases; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Female; Follow-Up Studies; Humans; Hydroxycholecalciferols; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Patient Acceptance of Health Care; Patient Dropouts; Phosphates; Phosphorus, Dietary; Renal Dialysis; Sepsis; Sevelamer | 2019 |
Denosumab for low bone mass in hemodialysis patients: a noncontrolled trial.
Topics: Aged; Antibodies, Monoclonal, Humanized; Biomarkers; Bone Density Conservation Agents; Bone Resorption; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Contraindications; Denosumab; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Osteoclasts; Prospective Studies; RANK Ligand; Renal Dialysis | 2015 |
Middle-term use of Cinacalcet in paediatric dialysis patients.
Topics: Adolescent; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Hypophosphatemia; Infant; Kidney Failure, Chronic; Male; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2010 |
An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism.
Topics: Biomarkers; Biopsy; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Double-Blind Method; Female; Fibrosis; Humans; Hyperparathyroidism, Secondary; Ilium; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Prospective Studies; Renal Dialysis | 2008 |
17 other study(ies) available for cinacalcet and CKD-MBD
| Article | Year |
|---|---|
Cinacalcet Improves Bone Parameters Through Regulation of Osteoclast Endoplasmic Reticulum Stress, Autophagy, and Apoptotic Pathways in Chronic Kidney Disease-Mineral and Bone Disorder.
Topics: Animals; Autophagy; Cell Differentiation; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Endoplasmic Reticulum Stress; Mice; Osteoclasts; RANK Ligand; X-Ray Microtomography | 2022 |
Characterization of Medication Trends for Chronic Kidney Disease: Mineral and Bone Disorder Treatment Using Electronic Health Record-Based Common Data Model.
Topics: Adult; Aged; Aged, 80 and over; Calcium-Regulating Hormones and Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Electronic Health Records; Female; Hospitals, University; Humans; Male; Middle Aged; Practice Guidelines as Topic; Receptors, Calcitriol; Renal Insufficiency, Chronic; Republic of Korea; Retrospective Studies; Tertiary Care Centers | 2021 |
Cinacalcet use in paediatric dialysis: a position statement from the European Society for Paediatric Nephrology and the Chronic Kidney Disease-Mineral and Bone Disorders Working Group of the ERA-EDTA.
Topics: Calcimimetic Agents; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Evidence-Based Medicine; Humans; Hyperparathyroidism, Secondary; Practice Guidelines as Topic; Renal Dialysis | 2020 |
Factors affecting the relationship between ionized and corrected calcium levels in peritoneal dialysis patients: a retrospective cross-sectional study.
Topics: Aged; Bone Density Conservation Agents; Calcium; Calcium-Regulating Hormones and Agents; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Cross-Sectional Studies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Retrospective Studies; Vitamin D | 2020 |
Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis Patients.
Topics: Aged; Calcimimetic Agents; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Peptides; Phosphates; Renal Dialysis; Retrospective Studies | 2020 |
Trajectories of CKD-MBD biochemical parameters over a 2-year period following diagnosis of secondary hyperparathyroidism: a pharmacoepidemiological study.
Topics: Adult; Alkaline Phosphatase; Calcimimetic Agents; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Female; Follow-Up Studies; France; Humans; Hyperparathyroidism, Secondary; Male; Models, Biological; Parathyroid Hormone; Pharmacoepidemiology; Prospective Studies; Reference Standards; Renal Dialysis; Treatment Outcome | 2017 |
Achieve Your Goals Together. The Easy and Reasonable Way to Treat Chronic Kidney Disease-Mineral Bone Disorder.
Topics: Calcitriol; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Goals; Humans; Hyperparathyroidism, Secondary; Minerals; Renal Dialysis; Renal Insufficiency, Chronic | 2018 |
Case report: Electron microscopic evaluation of bone from a patient treated with cinacalcet hydrochloride, maxacalcitol, and alfacalcidol for hyperparathyroid bone disease with secondary hyperparathyroidism.
Topics: Biopsy; Bone Density Conservation Agents; Calcitriol; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Ilium; Microscopy, Electron; Middle Aged | 2018 |
[New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy].
Topics: Calcimimetic Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Clinical Trials as Topic; Drug Therapy, Combination; Health Services Needs and Demand; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Parathyroid Glands; Parathyroid Hormone; Peptides; Receptors, Calcium-Sensing; Renal Dialysis; Renal Insufficiency, Chronic; Vitamin D | 2018 |
Chronic kidney failure mineral bone disorder leads to a permanent loss of hematopoietic stem cells through dysfunction of the stem cell niche.
Topics: Animals; Bone Density; Bone Marrow Diseases; Cell Count; Cell Cycle; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Disease Models, Animal; Endothelium, Vascular; Female; Hematopoietic Stem Cells; Homeostasis; Lymphopoiesis; Macrophages; Mice; Mice, Inbred C57BL; Nephrectomy; Osteoblasts; Stem Cell Niche | 2018 |
Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis.
Topics: Adult; Aged; Calcimimetic Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Death, Sudden, Cardiac; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Genetic Predisposition to Disease; Glucuronidase; Heart Failure; Humans; Hyperparathyroidism, Secondary; Kaplan-Meier Estimate; Klotho Proteins; Male; Middle Aged; Multicenter Studies as Topic; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic; Receptor, Fibroblast Growth Factor, Type 4; Renal Dialysis | 2019 |
Compliance with objectives based on different guidelines (KDIGO/S.E.N.) and analysis of the individual variability of mineral metabolism in haemodialysis patients in the medium term.
Topics: Aged; Calcium; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Ergocalciferols; Female; Follow-Up Studies; Goals; Guideline Adherence; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Peritoneal Dialysis; Phosphorus; Postoperative Complications; Practice Guidelines as Topic; Renal Dialysis; Retrospective Studies | 2013 |
Facial swelling in a child on chronic hemodialysis: Answers.
Topics: Calcimimetic Agents; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Edema; Face; Facial Bones; Humans; Kidney Failure, Chronic; Male; Osteitis Fibrosa Cystica; Renal Dialysis; Tomography, X-Ray Computed; Urogenital Abnormalities; Vesico-Ureteral Reflux | 2017 |
19th Annual Meeting of the Japanese Society for Kidney Bone Disease.
Topics: Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Receptors, Calcium-Sensing | 2008 |
Role of cinacalcet in management of mineral bone disorder in chronic kidney disease (control of calcium, phosphorus and parathyroid hormone).
Topics: Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Renal Dialysis; Treatment Outcome; Vitamin D | 2008 |
Impact of cinacalcet hydrochloride on bone histology in patients with secondary hyperparathyroidism.
Topics: Aged; Bone and Bones; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Drug Therapy, Combination; Fibrosis; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Osteoblasts; Parathyroid Hormone; Renal Dialysis; Time Factors; Vitamin D | 2008 |
Caring for chronic kidney disease patients: focus on mineral and bone disorders.
Topics: Calcium; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diet Therapy; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Metabolic Diseases; Middle Aged; Naphthalenes; Parathyroid Hormone; Pharmaceutical Services; Phosphorus; Receptors, Calcium-Sensing; Renal Dialysis; Vitamin D | 2009 |